Nordisk Gentofte A/S - leitarniðurstöður

Singapúr - enska - HSA (Health Sciences Authority)

nordiska calasept temp temporary dental filling

chee sang dental supply pte ltd - dental - ready to use temporary dental close-up material (temporary cement).

Singapúr - enska - HSA (Health Sciences Authority)

nordiska dental restorativerepair kit

chee sang dental supply pte ltd - dental - a collection of components designed to fill dental cavities or restore dental tissues. it does not include obturation of root canal.

Singapúr - enska - HSA (Health Sciences Authority)

nordiska restorative filling materials

chee sang dental supply pte ltd - dental - a collection of components designed to fill dental cavities or restore dental tissues.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

kliovance estradiol 1mg and norethisterone acetate 0.5mg tab dialdispenserpack

novo nordisk pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 1.03 mg (equivalent: estradiol, qty 1 mg); norethisterone acetate, quantity: 0.5 mg - tablet, film coated - excipient ingredients: maize starch; copovidone; lactose monohydrate; purified talc; hypromellose; triacetin; magnesium stearate - short term treatment of menopausal symptoms related to oestrogen deficiency in women more than one year after menopause (see dosage and administration and clinical trials). for the prevention of postmenopausal bone mineral density loss. when prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of osteoporosis and future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of osteoporosis. life style modifications and the risk benefit profiles of kliovance should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing. see precautions and dosage and administration.

Singapúr - enska - HSA (Health Sciences Authority)

novo nordisk novopen echo

novo nordisk pharma (singapore) pte ltd - general hospital - novo pen echo® is a re-usable mechanically driven pen injector designed for single-patient use by diabetics for the self-injection of a desired dose of insulin a dose setting range of 0.5 to 30 units in one half (1/2) unit increments.